HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 98/3/881    most recent 00486.2004v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Kovar, J. Articles by Sly, P. D. Search for Related Content PubMed PubMed Citation Articles by Kovar, J. Articles by Sly, P. D.

Impact of postnatal glucocorticoids on early lung development

¹Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Australia; and ²Unit of Developmental Vascular Biology, Institute of Child Health London, United Kingdom

Submitted 7 May 2004 ; accepted in final form 17 September 2004

Inhaled glucocorticoid treatment during the first 2 yr of life is controversial because this is a period of major structural remodeling of the lung. Rabbits received aerosolized budesonide (Bud; 250 µg/ml) or injected dexamethasone (Dex; 0.05 mg·ml^–1·kg^–1) between 1 and 5 wk of age. Treatment with Bud caused specific growth retardation of the lung. Dex but not Bud affected the mechanical properties of the lung parenchyma, when corrected for lung volume. Small peripheral airway walls in both glucocorticoid groups were thinner and had fewer alveolar attachment points with greater distance between attachments than controls, but collagen content was not affected by glucocorticoids. Dex led to reduced body weight, lung volume, alveolar number, and surface area. The alveolar size and number and elastin content, when related to lung volume, was not affected by Bud, suggesting normal structural development but inhibition of total growth. Arterial wall thickness and diameter were affected by Bud. This study demonstrates that developing lungs are sensitive to inhaled glucocorticoids. As such, the use of glucocorticoids in young infants and children should be monitored with caution and only the lowest doses that yield significant clinical improvement should be used.

lung function; morphometry; collagen; elastin; airway; rabbit

This article has been cited by other articles:

				A. Bush Practice Imperfect -- Treatment for Wheezing in Preschoolers N. Engl. J. Med., January 22, 2009; 360(4): 409 - 410. [Full Text] [PDF]

				A. Bush and I. Annesi-Maesano "Beam Me Up, Scotty!" Am. J. Respir. Crit. Care Med., January 1, 2007; 175(1): 1 - 2. [Full Text] [PDF]

				K. Huang, R. Rabold, B. Schofield, W. Mitzner, and C. G. Tankersley Age-dependent changes of airway and lung parenchyma in C57BL/6J mice J Appl Physiol, January 1, 2007; 102(1): 200 - 206. [Abstract] [Full Text] [PDF]

				P. J. F. M. Merkus and J. C. de Jongste Inhaled Corticosteroids in Wheezy Infants Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 1058 - 1059. [Full Text] [PDF]